Does MRI-guided TULSA provide a targeted approach to ablation?

Nature Reviews Urology, Published online: 26 November 2020; doi:10.1038/s41585-020-00403-7MRI-guided transurethral ultrasound ablation is an exciting, minimally invasive technology with the potential to provide targeted ablation of prostate cancer tissue. At 3 years, functional outcomes remain good with 76% remaining free from salvage treatment. Future studies using a focal approach may provide evidence for widespread uptake of this technology.
Source: Nature Reviews Urology - Category: Urology & Nephrology Authors: Source Type: research